Life Healthcare Group Limited (0928.HK)
HKD 0.05
(-7.69%)
HKD 0.05
(-7.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 17.63 Million HKD | 154.22% |
| 2022 | -32.52 Million HKD | -44.16% |
| 2021 | -22.56 Million HKD | -480.25% |
| 2020 | 5.93 Million HKD | 147.11% |
| 2019 | -12.59 Million HKD | 90.23% |
| 2018 | -128.9 Million HKD | -53.44% |
| 2017 | -84.01 Million HKD | -182.3% |
| 2016 | -29.75 Million HKD | 27.17% |
| 2015 | -40.86 Million HKD | 2.69% |
| 2014 | -41.99 Million HKD | 40.47% |
| 2013 | -70.53 Million HKD | 44.01% |
| 2012 | -125.98 Million HKD | -109.64% |
| 2011 | 1.3 Billion HKD | 13187.34% |
| 2010 | -9.98 Million HKD | -261.92% |
| 2009 | 6.16 Million HKD | 125.92% |
| 2008 | -23.79 Million HKD | 99.07% |
| 2007 | -2.57 Billion HKD | -1021.21% |
| 2006 | 279.08 Million HKD | 6.38% |
| 2005 | 262.34 Million HKD | 35.67% |
| 2004 | 193.37 Million HKD | 31.16% |
| 2003 | 147.43 Million HKD | 10.49% |
| 2002 | 133.44 Million HKD | 17.09% |
| 2001 | 113.96 Million HKD | 12.36% |
| 2000 | 101.43 Million HKD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | 2.77 Million HKD | 0.0% |
| 2023 Q4 | 14.85 Million HKD | 0.0% |
| 2023 FY | 17.63 Million HKD | 154.22% |
| 2022 Q2 | -2.42 Million HKD | 0.0% |
| 2022 FY | -32.52 Million HKD | -44.16% |
| 2022 Q4 | -30.1 Million HKD | 0.0% |
| 2021 Q2 | -1.23 Million HKD | 0.0% |
| 2021 Q4 | -21.32 Million HKD | 0.0% |
| 2021 FY | -22.56 Million HKD | -480.25% |
| 2020 Q4 | -6.75 Million HKD | 0.0% |
| 2020 FY | 5.93 Million HKD | 147.11% |
| 2020 Q2 | 5.53 Million HKD | 0.0% |
| 2019 Q4 | -2.56 Million HKD | 0.0% |
| 2019 FY | -12.59 Million HKD | 90.23% |
| 2019 Q2 | -6.46 Million HKD | 0.0% |
| 2018 Q2 | -42.57 Million HKD | 0.0% |
| 2018 FY | -128.9 Million HKD | -53.44% |
| 2017 FY | -84.01 Million HKD | -182.3% |
| 2017 Q2 | -37.05 Million HKD | 0.0% |
| 2016 Q2 | -14.83 Million HKD | 0.0% |
| 2016 FY | -29.75 Million HKD | 27.17% |
| 2015 Q2 | -17.98 Million HKD | 0.0% |
| 2015 Q4 | -22.87 Million HKD | 0.0% |
| 2015 FY | -40.86 Million HKD | 2.69% |
| 2014 Q2 | -27.72 Million HKD | -14.55% |
| 2014 Q1 | -24.2 Million HKD | 0.0% |
| 2014 FY | -41.99 Million HKD | 40.47% |
| 2014 Q4 | -14.26 Million HKD | 0.0% |
| 2013 Q1 | -29.35 Million HKD | 0.0% |
| 2013 FY | -70.53 Million HKD | 44.01% |
| 2013 Q4 | -24.2 Million HKD | 0.0% |
| 2013 Q3 | -24.2 Million HKD | 48.83% |
| 2013 Q2 | -47.29 Million HKD | -61.09% |
| 2012 Q1 | 326.75 Million HKD | 0.0% |
| 2012 FY | -125.98 Million HKD | -109.64% |
| 2012 Q4 | -29.35 Million HKD | 0.0% |
| 2012 Q3 | -29.35 Million HKD | -108.98% |
| 2012 Q2 | 326.75 Million HKD | 0.0% |
| 2011 Q4 | 326.75 Million HKD | 0.0% |
| 2011 FY | 1.3 Billion HKD | 13187.34% |
| 2011 Q1 | -2.49 Million HKD | 0.0% |
| 2011 Q2 | -2.49 Million HKD | 0.0% |
| 2011 Q3 | 326.75 Million HKD | 13187.34% |
| 2010 Q3 | -2.49 Million HKD | -261.92% |
| 2010 Q1 | 1.54 Million HKD | 0.0% |
| 2010 Q2 | 1.54 Million HKD | 0.0% |
| 2010 FY | -9.98 Million HKD | -261.92% |
| 2010 Q4 | -2.49 Million HKD | 0.0% |
| 2009 Q1 | -5.94 Million HKD | 0.0% |
| 2009 Q2 | -5.94 Million HKD | 0.0% |
| 2009 Q3 | 1.54 Million HKD | 125.92% |
| 2009 Q4 | 1.54 Million HKD | 0.0% |
| 2009 FY | 6.16 Million HKD | 125.92% |
| 2008 Q1 | -642.73 Million HKD | 0.0% |
| 2008 FY | -23.79 Million HKD | 99.07% |
| 2008 Q3 | -5.94 Million HKD | 99.07% |
| 2008 Q2 | -642.73 Million HKD | 0.0% |
| 2008 Q4 | -5.94 Million HKD | 0.0% |
| 2007 Q2 | 69.77 Million HKD | 0.0% |
| 2007 Q1 | 69.77 Million HKD | 0.0% |
| 2007 FY | -2.57 Billion HKD | -1021.21% |
| 2007 Q4 | -642.73 Million HKD | 0.0% |
| 2007 Q3 | -642.73 Million HKD | -1021.21% |
| 2006 Q3 | 69.77 Million HKD | 9.17% |
| 2006 Q2 | 63.9 Million HKD | 0.0% |
| 2006 Q1 | 63.9 Million HKD | 0.0% |
| 2006 FY | 279.08 Million HKD | 6.38% |
| 2006 Q4 | 69.77 Million HKD | 0.0% |
| 2005 Q4 | 63.9 Million HKD | 0.0% |
| 2005 Q2 | 46.16 Million HKD | 0.0% |
| 2005 Q1 | 46.16 Million HKD | 0.0% |
| 2005 FY | 262.34 Million HKD | 35.67% |
| 2005 Q3 | 63.9 Million HKD | 38.44% |
| 2004 Q4 | 46.16 Million HKD | 0.0% |
| 2004 Q1 | 36.7 Million HKD | 0.0% |
| 2004 FY | 193.37 Million HKD | 31.16% |
| 2004 Q2 | 36.7 Million HKD | 0.0% |
| 2004 Q3 | 46.16 Million HKD | 25.78% |
| 2003 Q4 | 36.7 Million HKD | 0.0% |
| 2003 Q2 | 33.01 Million HKD | 0.0% |
| 2003 Q3 | 36.7 Million HKD | 11.18% |
| 2003 FY | 147.43 Million HKD | 10.49% |
| 2003 Q1 | 33.01 Million HKD | 0.0% |
| 2002 Q2 | 28.1 Million HKD | 0.0% |
| 2002 Q1 | 28.1 Million HKD | 0.0% |
| 2002 FY | 133.44 Million HKD | 17.09% |
| 2002 Q4 | 33.01 Million HKD | 0.0% |
| 2002 Q3 | 33.01 Million HKD | 17.47% |
| 2001 Q3 | 28.1 Million HKD | 12.22% |
| 2001 Q2 | 25.04 Million HKD | 0.0% |
| 2001 Q1 | 25.04 Million HKD | 0.0% |
| 2001 FY | 113.96 Million HKD | 12.36% |
| 2001 Q4 | 28.1 Million HKD | 0.0% |
| 2000 Q4 | 25.04 Million HKD | 0.0% |
| 2000 Q3 | 25.04 Million HKD | 0.0% |
| 2000 FY | 101.43 Million HKD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| China Biotech Services Holdings Limited | -127.67 Million HKD | 113.812% |